Tag: holding

  • Roche Pharmaceutical Company

    Rapid scientific advances have place the gene therapy field at the forefront of biomedical analysis. But, as recent setbacks have shown, researchers and drugmakers nonetheless face main challenges. The regulator could quickly approve medicines from Apellis, Gilead and GSK, and make a decision no matter if to pull a controversial preterm birth drug from the […]